Amenamevir

CAS no.: 841301-32-4

Type: API

Usage: Antiviral, herpes

Technical description
Amenamevir has been used in trials studying the treatment of Herpes Zoster, Herpes Simplex, Herpes Genitalis, and Safety of Amenamevir. Amenamevir is a novel helicase-primase inhibitor that is active against varicella-zoster virus and herpes simplex virus types 1 and 2. Amenamenir stabilizes the interaction between the helicase-primase and its DNA substrates, preventing the progression through helicase or primase catalytic cycles, thus interfering with viral DNA replication and viral growth.

IUPAC name: N-(2,6-dimethylphenyl)-N-[2-[4-(1,2,4-oxadiazol-3-yl)anilino]-2-oxoethyl]-1,1-dioxothiane-4-carboxamide

Molecular formula: C₂₄H₂₆N₄O₅S

Molecular Weight: 482.6 g/mol

Class: Antiviral agent / Oxadiazol.